Sensus Healthcare Stock Forecast, Price & News

-0.02 (-0.53 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $3.78
50-Day Range
MA: $4.18
52-Week Range
Now: $3.78
Volume14,630 shs
Average Volume464,444 shs
Market Capitalization$62.32 million
P/E RatioN/A
Dividend YieldN/A
Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.
Sensus Healthcare logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:SRTS
Year FoundedN/A



Sales & Book Value

Annual Sales$27.26 million
Book Value$1.70 per share


Net Income$-1,700,000.00


Market Cap$62.32 million
Next Earnings Date5/6/2021 (Estimated)
OptionableNot Optionable


Sensus Healthcare Jumps After Posting Surprise Profit
February 26, 2021 |
News for Sensus Healthcare Inc
January 17, 2021 |
Sensus Healthcare EPS beats by $0.04, misses on revenue
November 5, 2020 |
Sensus Healthcare, Inc. to Host Earnings Call
November 5, 2020 |
See More Headlines


Overall MarketRank

1.35 out of 5 stars

Medical Sector

727th out of 2,010 stocks

Surgical & Medical Instruments Industry

72nd out of 168 stocks

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.02 (-0.53 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SRTS News and Ratings via Email

Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions

Is Sensus Healthcare a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Sensus Healthcare stock.
View analyst ratings for Sensus Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than Sensus Healthcare?

Wall Street analysts have given Sensus Healthcare a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sensus Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sensus Healthcare?

Sensus Healthcare saw a decrease in short interest in March. As of March 15th, there was short interest totaling 63,900 shares, a decrease of 68.5% from the February 28th total of 202,800 shares. Based on an average daily trading volume, of 482,600 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.6% of the shares of the stock are short sold.
View Sensus Healthcare's Short Interest

When is Sensus Healthcare's next earnings date?

Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Sensus Healthcare

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its quarterly earnings data on Thursday, February, 25th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.18. Sensus Healthcare had a negative net margin of 52.46% and a negative trailing twelve-month return on equity of 28.68%.
View Sensus Healthcare's earnings history

How has Sensus Healthcare's stock been impacted by COVID-19?

Sensus Healthcare's stock was trading at $3.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SRTS shares have increased by 16.3% and is now trading at $3.78.
View which stocks have been most impacted by COVID-19

What price target have analysts set for SRTS?

6 equities research analysts have issued twelve-month target prices for Sensus Healthcare's shares. Their forecasts range from $3.00 to $6.00. On average, they expect Sensus Healthcare's stock price to reach $4.98 in the next year. This suggests a possible upside of 31.8% from the stock's current price.
View analysts' price targets for Sensus Healthcare
or view top-rated stocks among Wall Street analysts.

Who are Sensus Healthcare's key executives?

Sensus Healthcare's management team includes the following people:
  • Mr. Joseph C. Sardano, Co-Founder, Chairman, CEO & Pres (Age 68, Pay $466.8k)
  • Mr. Stephen Cohen, Co-Founder & Exec. VP (Age 61, Pay $521.26k)
  • Mr. Javier Rampolla, Chief Financial Officer (Age 49)
  • Mr. Nicolas Soro, Chief Operating Officer (Age 36)
  • Mr. James Russell Price, Chief Technology Officer (Age 60)
  • Mr. Michael J. Sardano, VP, Gen. Counsel & Corp. Sec. (Age 33)
  • Mr. Benson Suen, VP of International Sales
  • Dr. Mark S. Nestor, Medical Director & Member of Medical Advisory Board
  • Dr. Clay Jefferies Cockerell, Clinical Director & Member of Medical Advisory Board (Age 64)

Who are some of Sensus Healthcare's key competitors?

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

How do I buy shares of Sensus Healthcare?

Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $3.78.

How much money does Sensus Healthcare make?

Sensus Healthcare has a market capitalization of $62.32 million and generates $27.26 million in revenue each year. The company earns $-1,700,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

How many employees does Sensus Healthcare have?

Sensus Healthcare employs 42 workers across the globe.

What is Sensus Healthcare's official website?

The official website for Sensus Healthcare is

Where are Sensus Healthcare's headquarters?

Sensus Healthcare is headquartered at 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected]

This page was last updated on 4/10/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.